Back to Search
Start Over
The search for treatments for inclusion body myositis.
- Source :
-
The Lancet. Neurology [Lancet Neurol] 2023 Oct; Vol. 22 (10), pp. 873-874. - Publication Year :
- 2023
-
Abstract
- Competing Interests: MdV has consulted for Novartis, Dynacure, and Argenx. JDB has participated on data safety monitoring boards or advisory boards for Argenx, Biogen, Sanofi, Alexion, UCB Pharma, Amylyx, and Amicus Pharma.
- Subjects :
- Humans
Myositis, Inclusion Body therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1474-4465
- Volume :
- 22
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- The Lancet. Neurology
- Publication Type :
- Academic Journal
- Accession number :
- 37739563
- Full Text :
- https://doi.org/10.1016/S1474-4422(23)00327-7